157P Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type mCRC: Japanese Skin Toxicity Evaluation Protocol with Panitumumab: J-STEPP/HGCSG1001: updated analysis of anti-tumor efficacy
Satoshi Yuki, Yoshito Komatsu, Hiroshi Nakatsumi, Toshiya Muranaka, Y. Kobayashi, T. Miyagishima, Nobuyuki Ehira, Ichiro Iwanaga, Hiroyuki Okuda, M. Tateyama, Yasushi Tsuji, Kazuteru Hatanaka, Michio Nakamura, Masatoshi Kudo, H. Fukushima, Hiroyuki Hisai, Riichiro Abe, Naoya Sakamoto, Koji Oba, Yuh Sakata (2015). 157P Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type mCRC: Japanese Skin Toxicity Evaluation Protocol with Panitumumab: J-STEPP/HGCSG1001: updated analysis of anti-tumor efficacy. , 26, DOI: https://doi.org/10.1093/annonc/mdv523.18.
